Janet Wale

1.9k total citations · 1 hit paper
48 papers, 1.1k citations indexed

About

Janet Wale is a scholar working on General Health Professions, Physiology and Molecular Biology. According to data from OpenAlex, Janet Wale has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in General Health Professions, 10 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in Janet Wale's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Receptor Mechanisms and Signaling (7 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Janet Wale is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Receptor Mechanisms and Signaling (7 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Janet Wale collaborates with scholars based in Australia, United States and Canada. Janet Wale's co-authors include Andrew J. Bilski, J.D. Fitzgerald, C. Raper, James W. Paterson, Roy G. Goldie, Anna Mae Scott, J. D. Fitzgerald, Peter D. Sly, Ferenc Peták and Domenico Spina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Journal of Applied Physiology.

In The Last Decade

Janet Wale

48 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)

1983 387 citations Andrew J. Bilski, Janet Wale et al. Journal of Cardiovascular Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janet Wale Australia	18	380	276	225	217	172	48	1.1k
Frank G. Williams United States	21	296 0.8×	373 1.4×	354 1.6×	89 0.4×	10 0.1×	53	1.3k
A. L. Finn United States	21	330 0.9×	267 1.0×	129 0.6×	81 0.4×	8 0.0×	57	1.5k
Manuel Worcel France	26	650 1.7×	353 1.3×	173 0.8×	1.7k 7.8×	31 0.2×	86	3.1k
David E. Longnecker United States	23	179 0.5×	378 1.4×	127 0.6×	433 2.0×	7 0.0×	75	1.7k
R. K. S. Lim United States	13	102 0.3×	326 1.2×	222 1.0×	91 0.4×	12 0.1×	19	890
Karen Aspry United States	18	177 0.5×	490 1.8×	38 0.2×	166 0.8×	15 0.1×	40	1.3k
D. M. Dunlop United Kingdom	12	166 0.4×	107 0.4×	57 0.3×	188 0.9×	83 0.5×	46	761
Tânia Leme da Rocha Martinez Brazil	15	80 0.2×	245 0.9×	125 0.6×	160 0.7×	10 0.1×	69	1.1k
Lucrecia Moreno Spain	17	379 1.0×	170 0.6×	121 0.5×	112 0.5×	10 0.1×	78	1.1k
James R. Bell Australia	27	530 1.4×	199 0.7×	175 0.8×	574 2.6×	12 0.1×	77	1.9k

Countries citing papers authored by Janet Wale

Since Specialization

Citations

This map shows the geographic impact of Janet Wale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Wale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Wale more than expected).

Fields of papers citing papers by Janet Wale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Wale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Wale. The network helps show where Janet Wale may publish in the future.

Co-authorship network of co-authors of Janet Wale

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Wale. A scholar is included among the top collaborators of Janet Wale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Wale. Janet Wale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cooper, Wendy A., Caroline Cooper, Stephen B. Fox, et al.. (2025). Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia. Pathology. 57(4). 425–436. 1 indexed citations

Bero, Lisa, Fiona Blyth, Jason N. Doctor, et al.. (2023). Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. The Medical Journal of Australia. 219(2). 80–89. 25 indexed citations

Bero, Lisa, Chung‐Wei Christine Lin, Fiona Blyth, et al.. (2023). Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care. Journal of Clinical Epidemiology. 165. 111204–111204. 2 indexed citations

Wale, Janet, et al.. (2022). Can We Afford to Exclude Patients Throughout Health Technology Assessment?. SHILAP Revista de lepidopterología. 3. 796344–796344. 6 indexed citations

Wale, Janet, et al.. (2022). Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa. SHILAP Revista de lepidopterología. 4. 810456–810456. 5 indexed citations

Segelov, Eva, Sanchia Aranda, David C. Currow, et al.. (2021). Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards. The Medical Journal of Australia. 214(11). 528–531. 3 indexed citations

Wale, Janet, et al.. (2020). Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies. International Journal of Technology Assessment in Health Care. 36(3). 197–203. 5 indexed citations

Scott, Anna Mae, et al.. (2017). Patient advocate perspectives on involvement in HTA: an international snapshot. Research Involvement and Engagement. 3(1). 2–2. 35 indexed citations

Wale, Janet, et al.. (2016). Moving beyond the rhetoric of patient input in health technology assessment deliberations. Australian Health Review. 41(2). 170–170. 15 indexed citations

10.

Atallah, Álvaro Nagib, et al.. (2013). Respiratory therapy for removing bronchial secretions in mechanically ventilated adult patients. Cochrane Database of Systematic Reviews. 1 indexed citations

11.

Watt, Amber M., Janet E. Hiller, Annette Braunack‐Mayer, et al.. (2012). The ASTUTE Health study protocol: Deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment. Implementation Science. 7(1). 101–101. 42 indexed citations

12.

Wale, Janet, et al.. (2011). The Cochrane Library review titles that are important to users of health care, a Cochrane Consumer Network project. Health Expectations. 16(4). e146–63. 5 indexed citations

13.

Santesso, Nancy, Tamara Rader, George A. Wells, et al.. (2009). Responsiveness of the Effective Consumer Scale (EC-17). The Journal of Rheumatology. 36(9). 2087–2091. 26 indexed citations

14.

Belizán, José M., et al.. (2009). Maternal and child health research focusing on interventions that involve consumer participation. International Journal of Gynecology & Obstetrics. 108(2). 154–155. 3 indexed citations

15.

Tugwell, Peter, Andrew Wilson, Peter Brooks, et al.. (2005). Attributes and skills of an effective musculoskeletal consumer.. PubMed. 32(11). 2257–61. 20 indexed citations

16.

Peták, Ferenc, Janet Wale, & Peter D. Sly. (1999). Effects of salbutamol and Ro-20-1724 on airway and parenchymal mechanics in rats. Journal of Applied Physiology. 87(4). 1373–1380. 18 indexed citations

17.

Sly, Peter D., et al.. (1995). Pirenzepine Blunts the Pulmonary Parenchymal Response to Inhaled Methacholine. Pulmonary Pharmacology. 8(2-3). 123–129. 16 indexed citations

18.

Bilski, Andrew J., et al.. (1988). The Pharmacology of Epanolol (ICI 141292–A New β1-Selective Adrenoceptor Partial Agonist. Journal of Cardiovascular Pharmacology. 12(2). 227–232. 4 indexed citations

19.

Bilski, Andrew J., et al.. (1976). Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 56(3). 362P–362P. 7 indexed citations

20.

Wale, Janet. (1970). The action of practolol and propranolol on the rabbit isolated atrium. European Journal of Pharmacology. 9(3). 387–390. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact